sb 203580 has been researched along with aldosterone in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (aldosterone) | Trials (aldosterone) | Recent Studies (post-2010) (aldosterone) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 25,333 | 1,517 | 4,169 |
Protein | Taxonomy | sb 203580 (IC50) | aldosterone (IC50) |
---|---|---|---|
Mineralocorticoid receptor | Homo sapiens (human) | 0.0048 | |
Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 0.043 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YP; Luo, Y; Rui, HL | 1 |
1 other study(ies) available for sb 203580 and aldosterone
Article | Year |
---|---|
[The role of MAPK/ERK1/2 signaling pathway in aldosterone stimulated transforming growth factor-beta1 synthesis in renal tubular epithelial cells].
Topics: Aldosterone; Anthracenes; Blotting, Western; Butadienes; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; Imidazoles; Kidney Tubules, Proximal; Mifepristone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Phosphorylation; Pyridines; Signal Transduction; Time Factors; Transforming Growth Factor beta1 | 2006 |